Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.

about

Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.

Item

http://www.wikidata.org/entity/Q41574368

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.

@en

type

Item

label

Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.

@en

prefLabel

Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.

@en

P1476

Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery

@en

P2093

Marisa K Kilgour

http://www.w3.org/2001/XMLSchema#string

Michael A Kennedy

http://www.w3.org/2001/XMLSchema#string

Rebecca Xu

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Licensed and Unlicensed NK Cells: Differential Roles in Cancer and Viral Control

Association between Perioperative Blood Transfusions and Clinical Outcomes in Patients Undergoing Bladder Cancer Surgery: A Systematic Review and Meta-Analysis Study

Effects of opioids on immunologic parameters that are relevant to anti-tumour immune potential in patients with cancer: a systematic literature review

Response to trauma and metabolic changes: posttraumatic metabolism

Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence

Perioperative Blood Transfusion Promotes Worse Outcomes of Bladder Cancer after Radical Cystectomy: A Systematic Review and Meta-Analysis

The roles of IFN gamma in protection against tumor development and cancer immunoediting

The hypercoagulable state of malignancy: pathogenesis and current debate

Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression

P31

scholarly article

P356

10.3390/IJMS18081787

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Leonard Angka

Rebecca C Auer

Sarwat T Khan

P5008

ScienceSource

P577

2017-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28817109

http://www.w3.org/2001/XMLSchema#string

P921

Aillse

hemic and immune systems

Achyolli

P932

5578175

http://www.w3.org/2001/XMLSchema#string